Teva Pharmaceutical Industries Ltd. (T1EV34)

Overview

Teva Pharmaceutical Industries Limited is a global leader in the development, manufacturing, marketing, and distribution of both generic and specialty medicines, as well as biopharmaceutical products. With operations spanning North America, Europe, Israel, and internationally, Teva focuses on providing a wide range of health solutions. The company is known for its extensive portfolio which includes various dosage forms like tablets, capsules, injectables, and more, tailored to treat a vast spectrum of conditions. Teva dedicates significant efforts to areas such as the central nervous system (CNS), respiratory, and oncology, aiming to advance healthcare and improve the quality of life for patients around the world. Established in 1901 and headquartered in Tel Aviv, Israel, Teva also engages in the production of active pharmaceutical ingredients and offers contract manufacturing services, supporting other entities in the pharmaceutical industry through an out-licensing platform.

Products and Services

• Generic Medicines: Teva provides a comprehensive range of generic medicines, encompassing various dosage forms like tablets, injectables, and more, catering to a myriad of health conditions.
• Specialty Medicines: The company's specialty medicine segment includes products for the treatment of conditions in CNS, respiratory diseases, and oncology. Notable offerings include:
• BENDEKA/TREANDA: Injections used for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma.
• COPAXONE: For relapsing forms of multiple sclerosis.
• AJOVY: Preventive treatment for migraine in adults.
• AUSTEDO: Addresses neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia.
• UZEDY: For the treatment of schizophrenia.
• Biopharmaceutical Products: Includes products like GRANIX, TRISENOX, LONQUEX, and TEVAGRASTIM/RATIOGRASTIM, among others, focusing on advanced therapies.
• Respiratory Products: A range of products designed for asthma and other respiratory conditions, including ProAir RespiClick, QVAR, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick.
• OTC Products: Teva offers over-the-counter products under brand names such as SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA, providing accessible health solutions.
• Active Pharmaceutical Ingredients (APIs) and Contract Manufacturing: The company provides APIs and offers contract manufacturing services, showing its versatility in the pharmaceutical industry.
• Collaborations and Licenses: Teva has entered into collaboration agreements with companies like MedinCell, Sanofi, Alvotech, and Biolojic Design Ltd., and holds a license agreement with MODAG GmbH. These partnerships enrich its product offerings and enhance its R&D capabilities.